Exploring beneficial bacteria for eye surface health
Understanding the microbial requirements for colonization and immunogenicity of commensal bacteria at the ocular surface
['FUNDING_R01'] · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · NIH-11128635
This work looks at how helpful bacteria on the eye surface can protect against infections and improve eye health.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF PITTSBURGH AT PITTSBURGH (nih funded) |
| Locations | 1 site (PITTSBURGH, UNITED STATES) |
| Trial ID | NIH-11128635 on ClinicalTrials.gov |
What this research studies
Current treatments for eye surface diseases often only relieve symptoms, but this project explores a new approach using the eye's natural bacteria. Researchers are focusing on a specific beneficial bacterium, Corynebacterium mastitidis, which has shown promise in protecting the eye from common infections. The goal is to understand how these good bacteria settle on the eye and how they trigger the body's immune system to fight off harmful germs. This knowledge could lead to new ways to prevent and treat chronic eye conditions.
Who could benefit from this research
Good fit: This foundational work is relevant for individuals experiencing chronic ocular surface diseases, recurrent eye infections, or those interested in microbiome-based therapies for eye health.
Not a fit: Patients with eye conditions unrelated to microbial imbalances or those seeking immediate symptom relief may not directly benefit from this early-stage research.
Why it matters
Potential benefit: If successful, this work could lead to new treatments that address the root causes of ocular surface diseases, potentially preventing infections and reducing the need for symptom-focused care.
How similar studies have performed: While the concept of microbiome manipulation is gaining traction, this specific approach to understanding ocular commensal bacteria for eye protection is a novel and promising area of investigation.
Where this research is happening
PITTSBURGH, UNITED STATES
- UNIVERSITY OF PITTSBURGH AT PITTSBURGH — PITTSBURGH, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: ST LEGER, ANTHONY J — UNIVERSITY OF PITTSBURGH AT PITTSBURGH
- Study coordinator: ST LEGER, ANTHONY J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.